Anti proliferative activity of ELACYTac (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells
Adams, David J ; Sandvold, Marit L ; Myhren, Finn ; Jacobsen, Tove F ; Giles, Frank ; Rizzieri, David A
Leukemia & lymphoma, 2008-04, Vol.49 (4), p.786-797 [Periódico revisado por pares]Texto completo disponível